Copyright Reports & Markets. All rights reserved.

Post-pandemic Era-Global Vial and Prefilled Syringe Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

Request for Sample of this report
Buy now

Table of Contents

    Global Vial and Prefilled Syringe Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

      1 Market Scope

      • 1.1 Product Details and Introduction
        • 1.1.1 Glass Vial and Prefilled Syringe -Product Introduction and Major Manufacturers
        • 1.1.2 Polymer Vial and Prefilled Syringe -Product Introduction and Major Manufacturers
      • 1.2 Market Snapshot
        • 1.2.1 Major Companies Overview
        • 1.2.2 Market Concentration
        • 1.2.3 Six-Year Compound Annual Growth Rate (CAGR)

      2 Regional Market Analysis

      • 2.1 China Vial and Prefilled Syringe Status and Prospect (2016-2027)
        • 2.1.1 China Vial and Prefilled Syringe Market Size and Growth Rate (2016-2027)
        • 2.1.2 China Vial and Prefilled Syringe Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.2 EU Vial and Prefilled Syringe Status and Prospect (2016-2027)
        • 2.2.1 EU Vial and Prefilled Syringe Market Size and Growth Rate (2016-2027)
        • 2.2.2 EU Vial and Prefilled Syringe Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.3 USA Vial and Prefilled Syringe Status and Prospect (2016-2027)
        • 2.3.1 USA Vial and Prefilled Syringe Market Size and Growth Rate (2016-2027)
        • 2.3.2 USA Vial and Prefilled Syringe Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.4 Japan Vial and Prefilled Syringe Status and Prospect (2016-2027)
        • 2.4.1 Japan Vial and Prefilled Syringe Market Size and Growth Rate (2016-2027)
        • 2.4.2 Japan Vial and Prefilled Syringe Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.5 India Vial and Prefilled Syringe Status and Prospect (2016-2027)
        • 2.5.1 India Vial and Prefilled Syringe Market Size and Growth Rate (2016-2027)
        • 2.5.2 India Vial and Prefilled Syringe Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.6 Southeast Asia Vial and Prefilled Syringe Status and Prospect (2016-2027)
        • 2.6.1 Southeast Asia Vial and Prefilled Syringe Market Size and Growth Rate (2016-2027)
        • 2.6.2 Southeast Asia Vial and Prefilled Syringe Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.7 South America Vial and Prefilled Syringe Status and Prospect (2016-2027)
        • 2.7.1 South America Vial and Prefilled Syringe Market Size and Growth Rate (2016-2027)
        • 2.7.2 South America Vial and Prefilled Syringe Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.8 Vial and Prefilled Syringe Status and Prospect (2016-2027)
        • 2.8.1 Vial and Prefilled Syringe Market Size and Growth Rate (2016-2027)
        • 2.8.2 Vial and Prefilled Syringe Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)

      3 Global Vial and Prefilled Syringe Market Assessment by Segment

      • 3.1 Global Vial and Prefilled Syringe Capacity and Growth Rate
      • 3.2 Global Vial and Prefilled Syringe Sales by Type
      • 3.3 Global Vial and Prefilled Syringe Sales Revenue by Type
      • 3.4 Global Vial and Prefilled Syringe Consumption by Application

      4 Global Vial and Prefilled Syringe Market Assessment by Regions

      • 4.1 Global Vial and Prefilled Syringe Production Analysis and Forecast by Regions (2016-2027)
      • 4.2 Global Vial and Prefilled Syringe Sales Analysis and Forecast by Regions (2016-2027)
      • 4.3 Global Vial and Prefilled Syringe Sales Revenue Analysis and Forecast by Regions (2016-2027)

      5 Value Chain (Impact of COVID-19)

      • 5.1 Vial and Prefilled Syringe Value Chain Analysis
        • 5.1.1 Upstream
        • 5.1.2 Downstream
      • 5.2 COVID-19 Impact on Vial and Prefilled Syringe Industry
        • 5.2.1 Industrial Policy Issued Under the Epidemic Situation
      • 5.3 Cost-Under the Epidemic Situation
        • 5.3.1 Cost of Raw Material
      • 5.4 Channel Analysis
        • 5.4.1 Distribution Channel-Under the Epidemic Situation
        • 5.4.2 Distributors

      6 Competitive Landscape

      • 6.1 Global Vial and Prefilled Syringe Capacity Market Share of Manufacturers (2019-2020)
      • 6.2 Global Vial and Prefilled Syringe Sales Market Share of Manufacturers (2019-2020)
      • 6.3 Global Vial and Prefilled Syringe Sales Revenue Market Share of Manufacturers (2019-2020)

      7 Vial and Prefilled Syringe Competitive Analysis

      • 7.1 BD (US)
        • 7.1.1 BD (US) Company Profiles
        • 7.1.2 BD (US) Product Introduction
        • 7.1.3 BD (US) Vial and Prefilled Syringe Production, Revenue (2015-2020)
        • 7.1.4 SWOT Analysis
      • 7.2 Gerresheimer (DE)
        • 7.2.1 Gerresheimer (DE) Company Profiles
        • 7.2.2 Gerresheimer (DE) Product Introduction
        • 7.2.3 Gerresheimer (DE) Vial and Prefilled Syringe Production, Revenue (2015-2020)
        • 7.2.4 SWOT Analysis
      • 7.3 Nipro Corporation (JP)
        • 7.3.1 Nipro Corporation (JP) Company Profiles
        • 7.3.2 Nipro Corporation (JP) Product Introduction
        • 7.3.3 Nipro Corporation (JP) Vial and Prefilled Syringe Production, Revenue (2015-2020)
        • 7.3.4 SWOT Analysis
      • 7.4 Schott forma vitrum (DE)
        • 7.4.1 Schott forma vitrum (DE) Company Profiles
        • 7.4.2 Schott forma vitrum (DE) Product Introduction
        • 7.4.3 Schott forma vitrum (DE) Vial and Prefilled Syringe Production, Revenue (2015-2020)
        • 7.4.4 SWOT Analysis
      • 7.5 Ompi (IT)
        • 7.5.1 Ompi (IT) Company Profiles
        • 7.5.2 Ompi (IT) Product Introduction
        • 7.5.3 Ompi (IT) Vial and Prefilled Syringe Production, Revenue (2015-2020)
        • 7.5.4 SWOT Analysis
      • 7.6 Baxter BioPharma Solution (US)
        • 7.6.1 Baxter BioPharma Solution (US) Company Profiles
        • 7.6.2 Baxter BioPharma Solution (US) Product Introduction
        • 7.6.3 Baxter BioPharma Solution (US) Vial and Prefilled Syringe Production, Revenue (2015-2020)
        • 7.6.4 SWOT Analysis
      • 7.7 ROVI CM (ES)
        • 7.7.1 ROVI CM (ES) Company Profiles
        • 7.7.2 ROVI CM (ES) Product Introduction
        • 7.7.3 ROVI CM (ES) Vial and Prefilled Syringe Production, Revenue (2015-2020)
        • 7.7.4 SWOT Analysis
      • 7.8 Terumo (JP)
        • 7.8.1 Terumo (JP) Company Profiles
        • 7.8.2 Terumo (JP) Product Introduction
        • 7.8.3 Terumo (JP) Vial and Prefilled Syringe Production, Revenue (2015-2020)
        • 7.8.4 SWOT Analysis
      • 7.9 Vetter (DE)
        • 7.9.1 Vetter (DE) Company Profiles
        • 7.9.2 Vetter (DE) Product Introduction
        • 7.9.3 Vetter (DE) Vial and Prefilled Syringe Production, Revenue (2015-2020)
        • 7.9.4 SWOT Analysis
      • 7.10 Unilife Corporation (US)
        • 7.10.1 Unilife Corporation (US) Company Profiles
        • 7.10.2 Unilife Corporation (US) Product Introduction
        • 7.10.3 Unilife Corporation (US) Vial and Prefilled Syringe Production, Revenue (2015-2020)
        • 7.10.4 SWOT Analysis
      • 7.11 Taisei Kako (JP)
      • 7.12 Roselabs Group (IN)
      • 7.13 ARTE CORPORATION (JP)
      • 7.14 Weigao Group Medical Polymer (CN)
      • 7.15 Zibo Minkang Pharmaceutical (CN)
      • 7.16 Shandong Pharmaceutical Glass (CN)

      8 Conclusion

      Summary

      World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.

      Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.

      XYZResearch’s analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.

      This research report indicated that the global Vial and Prefilled Syringe market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.

      Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Vial and Prefilled Syringe Market by XYZResearch Include
      China
      EU
      North America
      Japan
      India
      Southeast Asia
      South America
      Middle East and Africa
      Competitive Analysis; Who are the Major Players in Vial and Prefilled Syringe Market?
      BD (US)
      Gerresheimer (DE)
      Nipro Corporation (JP)
      Schott forma vitrum (DE)
      Ompi (IT)
      Baxter BioPharma Solution (US)
      ROVI CM (ES)
      Terumo (JP)
      Vetter (DE)
      Unilife Corporation (US)
      Taisei Kako (JP)
      Roselabs Group (IN)
      ARTE CORPORATION (JP)
      Weigao Group Medical Polymer (CN)
      Zibo Minkang Pharmaceutical (CN)
      Shandong Pharmaceutical Glass (CN)
      ...
      Major Type of Vial and Prefilled Syringe Covered in XYZResearch report:
      Glass Vial and Prefilled Syringe
      Polymer Vial and Prefilled Syringe
      Application Segments Covered in XYZResearch Market
      Antithrombotics
      Vaccines
      Autoimmune Diseases
      Anti-inflammatory Drugs
      Other

      For any other requirements, please feel free to contact us and we will provide you customized report.
      Buy now